StockMarketWire.com - Societe Generale today reaffirms its buy investment rating on GlaxoSmithKline PLC [LON:GSK] and raised its price target to 2300p (from 2200p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk